1yat

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The protein phosphatase calcineurin is the putative target for the, immunosuppressive drug FK-506. The enzyme is inhibited by the complex of, the drug with its intracellular receptor, the 12-kDa FK-506-binding, protein (FKBP12), and the strength of inhibition usually correlates, strongly with immunosuppressive potency. We find, however, that the, complex of yeast FKBP12 with L-685,818, a well characterized antagonist of, FK-506 immunosuppression, is a potent inhibitor of calcineurin. The, corresponding human complex does not inhibit the enzyme, and both human, and yeast complexes with FK-506 do inhibit. To understand the structural, basis of these findings, we have determined the three-dimensional, structure of the complex of yeast FKBP12 with FK-506 by x-ray, crystallography, and have found that the structure of the yeast complex is, strikingly similar to its human homolog. These observations indicate that, specific sequence elements in the yeast protein provide stronger binding, interactions with a heterologous calcineurin than do the corresponding, elements in the human protein, and suggest structural modifications that, may improve the potency of this class of immunosuppressants.
+
The protein phosphatase calcineurin is the putative target for the immunosuppressive drug FK-506. The enzyme is inhibited by the complex of the drug with its intracellular receptor, the 12-kDa FK-506-binding protein (FKBP12), and the strength of inhibition usually correlates strongly with immunosuppressive potency. We find, however, that the complex of yeast FKBP12 with L-685,818, a well characterized antagonist of FK-506 immunosuppression, is a potent inhibitor of calcineurin. The corresponding human complex does not inhibit the enzyme, and both human and yeast complexes with FK-506 do inhibit. To understand the structural basis of these findings, we have determined the three-dimensional structure of the complex of yeast FKBP12 with FK-506 by x-ray crystallography, and have found that the structure of the yeast complex is strikingly similar to its human homolog. These observations indicate that specific sequence elements in the yeast protein provide stronger binding interactions with a heterologous calcineurin than do the corresponding elements in the human protein, and suggest structural modifications that may improve the potency of this class of immunosuppressants.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Saccharomyces cerevisiae]]
[[Category: Saccharomyces cerevisiae]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Becker, J.W.]]
+
[[Category: Becker, J W.]]
[[Category: Rotonda, J.]]
[[Category: Rotonda, J.]]
[[Category: FK5]]
[[Category: FK5]]
[[Category: binding protein]]
[[Category: binding protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:11:22 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:03:27 2008''

Revision as of 14:03, 21 February 2008


1yat, resolution 2.5Å

Drag the structure with the mouse to rotate

IMPROVED CALCINEURIN INHIBITION BY YEAST FKBP12-DRUG COMPLEXES. CRYSTALLOGRAPHIC AND FUNCTIONAL ANALYSIS

Overview

The protein phosphatase calcineurin is the putative target for the immunosuppressive drug FK-506. The enzyme is inhibited by the complex of the drug with its intracellular receptor, the 12-kDa FK-506-binding protein (FKBP12), and the strength of inhibition usually correlates strongly with immunosuppressive potency. We find, however, that the complex of yeast FKBP12 with L-685,818, a well characterized antagonist of FK-506 immunosuppression, is a potent inhibitor of calcineurin. The corresponding human complex does not inhibit the enzyme, and both human and yeast complexes with FK-506 do inhibit. To understand the structural basis of these findings, we have determined the three-dimensional structure of the complex of yeast FKBP12 with FK-506 by x-ray crystallography, and have found that the structure of the yeast complex is strikingly similar to its human homolog. These observations indicate that specific sequence elements in the yeast protein provide stronger binding interactions with a heterologous calcineurin than do the corresponding elements in the human protein, and suggest structural modifications that may improve the potency of this class of immunosuppressants.

About this Structure

1YAT is a Single protein structure of sequence from Saccharomyces cerevisiae with as ligand. Full crystallographic information is available from OCA.

Reference

Improved calcineurin inhibition by yeast FKBP12-drug complexes. Crystallographic and functional analysis., Rotonda J, Burbaum JJ, Chan HK, Marcy AI, Becker JW, J Biol Chem. 1993 Apr 15;268(11):7607-9. PMID:7681823

Page seeded by OCA on Thu Feb 21 16:03:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools